Cargando…

Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer

BACKGROUND: Immunohistochemistry (IHC) is often used in personalisation of cancer treatments. Analysis of large data sets to uncover predictive biomarkers by specialists can be enormously time-consuming. Here we investigated crowdsourcing as a means of reliably analysing immunostained cancer samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Smittenaar, Peter, Walker, Alexandra K., McGill, Shaun, Kartsonaki, Christiana, Robinson-Vyas, Rupesh J., McQuillan, Janette P., Christie, Sarah, Harris, Leslie, Lawson, Jonathan, Henderson, Elizabeth, Howat, Will, Hanby, Andrew, Thomas, Gareth J., Bhattarai, Selina, Browning, Lisa, Kiltie, Anne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048059/
https://www.ncbi.nlm.nih.gov/pubmed/29991697
http://dx.doi.org/10.1038/s41416-018-0156-0
_version_ 1783340034330460160
author Smittenaar, Peter
Walker, Alexandra K.
McGill, Shaun
Kartsonaki, Christiana
Robinson-Vyas, Rupesh J.
McQuillan, Janette P.
Christie, Sarah
Harris, Leslie
Lawson, Jonathan
Henderson, Elizabeth
Howat, Will
Hanby, Andrew
Thomas, Gareth J.
Bhattarai, Selina
Browning, Lisa
Kiltie, Anne E.
author_facet Smittenaar, Peter
Walker, Alexandra K.
McGill, Shaun
Kartsonaki, Christiana
Robinson-Vyas, Rupesh J.
McQuillan, Janette P.
Christie, Sarah
Harris, Leslie
Lawson, Jonathan
Henderson, Elizabeth
Howat, Will
Hanby, Andrew
Thomas, Gareth J.
Bhattarai, Selina
Browning, Lisa
Kiltie, Anne E.
author_sort Smittenaar, Peter
collection PubMed
description BACKGROUND: Immunohistochemistry (IHC) is often used in personalisation of cancer treatments. Analysis of large data sets to uncover predictive biomarkers by specialists can be enormously time-consuming. Here we investigated crowdsourcing as a means of reliably analysing immunostained cancer samples to discover biomarkers predictive of cancer survival. METHODS: We crowdsourced the analysis of bladder cancer TMA core samples through the smartphone app ‘Reverse the Odds’. Scores from members of the public were pooled and compared to a gold standard set scored by appropriate specialists. We also used crowdsourced scores to assess associations with disease-specific survival. RESULTS: Data were collected over 721 days, with 4,744,339 classifications performed. The average time per classification was approximately 15 s, with approximately 20,000 h total non-gaming time contributed. The correlation between crowdsourced and expert H-scores (staining intensity × proportion) varied from 0.65 to 0.92 across the markers tested, with six of 10 correlation coefficients at least 0.80. At least two markers (MRE11 and CK20) were significantly associated with survival in patients with bladder cancer, and a further three markers showed results warranting expert follow-up. CONCLUSIONS: Crowdsourcing through a smartphone app has the potential to accurately screen IHC data and greatly increase the speed of biomarker discovery.
format Online
Article
Text
id pubmed-6048059
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60480592019-07-17 Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer Smittenaar, Peter Walker, Alexandra K. McGill, Shaun Kartsonaki, Christiana Robinson-Vyas, Rupesh J. McQuillan, Janette P. Christie, Sarah Harris, Leslie Lawson, Jonathan Henderson, Elizabeth Howat, Will Hanby, Andrew Thomas, Gareth J. Bhattarai, Selina Browning, Lisa Kiltie, Anne E. Br J Cancer Article BACKGROUND: Immunohistochemistry (IHC) is often used in personalisation of cancer treatments. Analysis of large data sets to uncover predictive biomarkers by specialists can be enormously time-consuming. Here we investigated crowdsourcing as a means of reliably analysing immunostained cancer samples to discover biomarkers predictive of cancer survival. METHODS: We crowdsourced the analysis of bladder cancer TMA core samples through the smartphone app ‘Reverse the Odds’. Scores from members of the public were pooled and compared to a gold standard set scored by appropriate specialists. We also used crowdsourced scores to assess associations with disease-specific survival. RESULTS: Data were collected over 721 days, with 4,744,339 classifications performed. The average time per classification was approximately 15 s, with approximately 20,000 h total non-gaming time contributed. The correlation between crowdsourced and expert H-scores (staining intensity × proportion) varied from 0.65 to 0.92 across the markers tested, with six of 10 correlation coefficients at least 0.80. At least two markers (MRE11 and CK20) were significantly associated with survival in patients with bladder cancer, and a further three markers showed results warranting expert follow-up. CONCLUSIONS: Crowdsourcing through a smartphone app has the potential to accurately screen IHC data and greatly increase the speed of biomarker discovery. Nature Publishing Group UK 2018-07-11 2018-07-17 /pmc/articles/PMC6048059/ /pubmed/29991697 http://dx.doi.org/10.1038/s41416-018-0156-0 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Smittenaar, Peter
Walker, Alexandra K.
McGill, Shaun
Kartsonaki, Christiana
Robinson-Vyas, Rupesh J.
McQuillan, Janette P.
Christie, Sarah
Harris, Leslie
Lawson, Jonathan
Henderson, Elizabeth
Howat, Will
Hanby, Andrew
Thomas, Gareth J.
Bhattarai, Selina
Browning, Lisa
Kiltie, Anne E.
Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title_full Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title_fullStr Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title_full_unstemmed Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title_short Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
title_sort harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048059/
https://www.ncbi.nlm.nih.gov/pubmed/29991697
http://dx.doi.org/10.1038/s41416-018-0156-0
work_keys_str_mv AT smittenaarpeter harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT walkeralexandrak harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT mcgillshaun harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT kartsonakichristiana harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT robinsonvyasrupeshj harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT mcquillanjanettep harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT christiesarah harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT harrisleslie harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT lawsonjonathan harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT hendersonelizabeth harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT howatwill harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT hanbyandrew harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT thomasgarethj harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT bhattaraiselina harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT browninglisa harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer
AT kiltieannee harnessingcitizensciencethroughmobilephonetechnologytoscreenforimmunohistochemicalbiomarkersinbladdercancer